161 related articles for article (PubMed ID: 16740789)
61. [Therapy of lung cancer].
Ostoros G
Orv Hetil; 2004 Jan; 145(1):33-4. PubMed ID: 15222139
[No Abstract] [Full Text] [Related]
62. Overview of past, present and future of the EORTC Lung Cancer Group. European Organisation for Research and Treatment of Cancer.
Debruyne C; Giaccone G;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S100-6. PubMed ID: 11858974
[TBL] [Abstract][Full Text] [Related]
63. When is a cancer treatment worthwhile?
Tannock IF; Boyer M
N Engl J Med; 1990 Oct; 323(14):989-90. PubMed ID: 2169589
[No Abstract] [Full Text] [Related]
64. Management of non-small cell and small cell lung cancer.
Splinter TA
Curr Opin Oncol; 1991 Apr; 3(2):312-9. PubMed ID: 1648972
[TBL] [Abstract][Full Text] [Related]
65. Management of lung cancer--Chiangmai, Thailand, 24-26 February, 1999.
Thai Society of Clinical Oncology
Lung Cancer; 1999 Dec; 26(3):199-203. PubMed ID: 10598931
[No Abstract] [Full Text] [Related]
66. Promising lung cancer vaccine.
Environ Health Perspect; 1996 Nov; 104(11):1147-8. PubMed ID: 8959399
[No Abstract] [Full Text] [Related]
67. [Clinical and experimental studies on lung cancer].
Wu SF
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Feb; 7(1):47-50. PubMed ID: 6088190
[No Abstract] [Full Text] [Related]
68. Interferon and lung cancer.
Mattson KV; Hand AM; Maasilta PK
Cancer Treat Res; 1995; 72():293-321. PubMed ID: 7535556
[No Abstract] [Full Text] [Related]
69. Lung and mediastinum.
Curr Opin Oncol; 1995 Mar; 7(2):B39-45. PubMed ID: 7756371
[No Abstract] [Full Text] [Related]
70. [New therapeutic strategies in microcytoma].
Comella G; Panza N
Minerva Endocrinol; 2001 Dec; 26(4):261. PubMed ID: 11782712
[No Abstract] [Full Text] [Related]
71. Open access follow-up for lung cancer: patient and staff satisfaction.
Adlard JW; Joseph J; Brammer CV; Gerrard GE
Clin Oncol (R Coll Radiol); 2001; 13(6):404-8. PubMed ID: 11824875
[TBL] [Abstract][Full Text] [Related]
72. Comments on Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group, van Zandwijk et al., Eur J Cancer 1997, 33, 1759-1766.
Prior C; Thaler J; Huber H
Eur J Cancer; 1998 Sep; 34(10):1638. PubMed ID: 9893643
[No Abstract] [Full Text] [Related]
73. Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998.
Leigh BR; Gandara DR; Crowley JJ; Furuse K; Livingston RB; Fukushima M; Coltman CA
Lung Cancer; 1999 Jun; 24(3):181-91. PubMed ID: 10460006
[No Abstract] [Full Text] [Related]
74. New therapeutic strategies for lung cancer: biology and molecular biology come of age.
Bunn PA; Soriano A; Johnson G; Heasley L
Chest; 2000 Apr; 117(4 Suppl 1):163S-168S. PubMed ID: 10777473
[TBL] [Abstract][Full Text] [Related]
75. [The prospects of cure for small cell lung cancer].
Katan R; Katan H; Robinson E
Harefuah; 1979 Dec; 97(11-12):309-10. PubMed ID: 16296118
[No Abstract] [Full Text] [Related]
76. Applications of urinary nucleosides in cancer diagnosis and cancer management.
Sharma OK; Waalkes TP; Gehrke CW; Borek E
Cancer Detect Prev; 1983; 6(1-2):77-85. PubMed ID: 6309388
[No Abstract] [Full Text] [Related]
77. [New treatments of cancer & leukemia].
BERNARD J
Acquis Med Recent; 1957; ():113-24. PubMed ID: 13532171
[No Abstract] [Full Text] [Related]
78. [Oncological problems. I].
Neretto G
Minerva Med; 1979 Jul; 70(31):2225-6. PubMed ID: 450327
[No Abstract] [Full Text] [Related]
79. Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.
Paskett ED; Schrag D; Kornblith A; Lamont EB; Weeks JC; Marshall JR; Shapiro C; Holland J
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3601s-5s. PubMed ID: 16740792
[TBL] [Abstract][Full Text] [Related]
80. [Responsibility of physicians treating cancer patients. Scientific Committee of Public Health].
Orv Hetil; 1995 Apr; 136(16):837-8. PubMed ID: 7644191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
